REGISTERED NUMBER: 09364980 (England and Wales)

ABBREVIATED UNAUDITED ACCOUNTS

FOR THE PERIOD

22 DECEMBER 2014 TO 30 SEPTEMBER 2015

FOR

HEART BIOTECH LIPO LIMITED

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

3

DIRECTORS:

Mr S E O A Diab

Professor M A Ishak-Hanna

Mr S S Khoury

Mr M C Radford

Mr I A Richardson

Professor M H Yacoub

REGISTERED OFFICE:

1st Floor

18 Hanover Street

London

W1S 1YN

REGISTERED NUMBER:

09364980 (England and Wales)

ACCOUNTANTS:

Banks BHG, Chartered Accountants

Vicarage Court

160 Ermin Street

Swindon

Wiltshire

SN3 4NE

CURRENT ASSETS

Debtors

1

TOTAL ASSETS LESS CURRENT LIABILITIES

1

CAPITAL AND RESERVES

Called up share capital

2

1

SHAREHOLDERS' FUNDS

1

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2015.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 26 March 2016 and were signed on its behalf by:

Professor M A Ishak-Hanna - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in

accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).

The company was dormant throughout the period ended 30 September 2015.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed

at the balance sheet date.

2.	CALLED UP SHARE CAPITAL

Allotted and issued:

Number:

Class:

Nominal

value:

£

1

Share capital 1

£1

1

1 Ordinary share of £1 was allotted at par during the period.

3.	ULTIMATE CONTROLLING PARTY

Heart Biotech Holdings Limited is regarded by the directors as being the company's ultimate

parent company.